Open the mobile version, with barcode scanning
Class II Ongoing

Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by:…

Why: CGMP Deviations: use of an unapproved raw material

Company
Teva Pharmaceuticals USA, Inc
Parsippany, NJ, United States
Reported
Apr 15, 2026
Recall started
Mar 19, 2026
Where sold
Within U.S
Amount
124,054 Cartons
Full product description
Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3508-04 carton, NDC 0591-3508-54 pouch
Lots / codes affected
Lot: 100060315, Exp.: 04/2026; 100068644, Exp.: 01/2027.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.